Background: Hypogonadism predicts T2DM and is highly prevalent in men with prediabetes.

Methods: Pooled data from 2 ongoing urological registries. 303 men had prediabetes by HbA1c according to ADA definition. 220 received treatment with 3-monthly injections of testosterone undecanoate (TU; T-group), 83 served as controls (CTRL). Anthropometric and metabolic parameters were measured over 8 years.

Results: Mean follow-up: 6.6 years (T-group), 5.6 years (CTRL). Mean age: 60.6±9.6 years. Under TU, HbA1c decreased from 5.9±0.2 to 5.5±0.3% at 8 years (p<0.0001). In CTRL, HbA1c increased from 5.9±0.2 to 6.1±0.6% (p<0.0005). At the last observation, all 220 patients (100%) in the T-group had an HbA1c <6.5%. In CTRL, 35 men (42.2%) had progressed to T2DM with HbA1c >6.5% The TyG index, a surrogate parameter for insulin resistance, decreased in the T-group from 9.3±0.4 to 9.0±0.4 at 8 years. In CTRL, the index increased from 8.9±0.6 to 9.3±0.4 at 8 years. At baseline, 158 men (52.1%) were obese, 126 men (41.6%) were overweight and 19 (6.3%) had normal weight. Weight decreased from 96.7±12.3 to 89.0±9.6 kg in the T-group and increased from 92.9±10.4 to 98.2±6.3 kg in CTRL. Waist circumference decreased from 104.2±7.1 to 98.2±6.5 cm in the T-group and increased from 102.5±9.7 to 106±3.2 cm in CTRL. Weight loss was 9.2±8.3% at 8 years in the T-group. In CTRL, weight increased by 9.2±3.9% at 8 years (p<0.0001 for all). Adherence to TU was 100 per cent as all injections were performed and documented in the office.

Conclusion: Testosterone therapy prevented progression from prediabetes to T2DM in hypogonadal men while more than 40% of untreated hypogonadal men developed T2DM. This effect may have been supported by sustained weight loss and been mediated by the invariable increase in lean mass achieved by testosterone.


F. Saad: Employee; Self; Bayer AG. Stock/Shareholder; Self; Bayer AG, Novo Nordisk A/S. A. Haider: Research Support; Self; Bayer AG. K.S. Haider: Other Relationship; Self; Bayer AG.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at